BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20160469)

  • 21. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
    Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA;
    J Am Coll Cardiol; 2003 Jun; 41(11):2010-7. PubMed ID: 12798574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.
    Song BG; Jeon ES; Kim YH; Kang MK; Doh JH; Kim PH; Ahn SJ; Oh HL; Kim HJ; Sung JD; Lee SC; Gwon HC; Kim JS; Kim DK; Lee SH; Hong KP; Park JE; Lee SY; Lee JK
    Korean J Intern Med; 2005 Mar; 20(1):26-32. PubMed ID: 15906950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Cat S, TSP-1, IL-11, BNP and sST2 Diagnostic and Prognostic Value in Chronic Heart Failure.
    Xiang Y; Zhang Z; Xie C; Wang L; Wu Y; Zhan Y; Chen D
    Altern Ther Health Med; 2022 May; 28(4):55-59. PubMed ID: 35452416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
    Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
    Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.
    McNairy M; Gardetto N; Clopton P; Garcia A; Krishnaswamy P; Kazanegra R; Ziegler M; Maisel AS
    Am Heart J; 2002 Mar; 143(3):406-11. PubMed ID: 11868044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular systolic/diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis.
    Nakae I; Matsuo S; Koh T; Mitsunami K; Horie M
    Ann Nucl Med; 2005 Sep; 19(6):447-54. PubMed ID: 16248380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-type natriuretic Peptide predicts clinical presentations and ventricular overloading in patients with heart failure.
    Joung BY; Park BE; Kim DS; Hong BK; Kim DY; Cho YH; Lee SH; Yoon YW; Kim HS; Kim JH; Kwon HM
    Yonsei Med J; 2003 Aug; 44(4):623-34. PubMed ID: 12950118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of BNP for an early diagnosis of asymptomatic left ventricular dysfunction: a retrospective study.
    De Vecchis R; Esposito C; Ariano C; Di Biase G
    Minerva Cardioangiol; 2014 Apr; 62(2):147-59. PubMed ID: 24686994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
    Frantz RP; Olson LJ; Grill D; Moualla SK; Nelson SM; Nobrega TP; Hanna RD; Backes RJ; Mookadam F; Heublein D; Bailey KR; Burnett JC
    Am Heart J; 2005 Mar; 149(3):541-7. PubMed ID: 15864245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients.
    Aessopos A; Farmakis D; Polonifi A; Tsironi M; Fragodimitri C; Hatziliami A; Karagiorga M; Diamanti-Kandarakis E
    Eur J Heart Fail; 2007 May; 9(5):537-41. PubMed ID: 17300987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.
    Gustafsson F; Steensgaard-Hansen F; Badskjaer J; Poulsen AH; Corell P; Hildebrandt P
    J Card Fail; 2005 Jun; 11(5 Suppl):S15-20. PubMed ID: 15948095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.